Diseases
Lebrikizumab Delivers Long-Term Atopic Dermatitis Control
Up to 4 years of sustained skin clearance and itch relief in moderate-to-severe cases
Navigator Medicines Advances Bispecific Antibody Programs for Hidradenitis Suppurativa
Company Initiates Phase 2a Trial for NAV-240 and Enters Phase 1 for Next-Gen NAV-242
Colorado Moves to Regulate Cancer-Causing Air Toxins
State regulators propose new rules to cut emissions of industrial chemicals linked to serious illnesses
- TriStar StoneCrest Medical Center Names Ryan LeMasters CEO
- Denver Nuggets Clinch Playoffs With Suns Loss, Lakers Win
- Nuggets' Cam Johnson exits Warriors game with apparent injury
- Denver's Petals & Pages Bookstore to Close Next Month
- Red Rocks Expands 2026 Concert Lineup with Fogerty, Allen, and More
- Denver Kicks Off Annual Street Sweeping Program
